Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Merchants’ Gate Capital was a New York-based global long/short equity hedge fund manager founded in 2007 by Jason Capello, a former director of research at Ospraie Management. The firm operated as a "Tiger Cub," having received early backing and influence from the lineage of Julian Robertson's Tiger Management. While it invested across various sectors including energy, industrials, and consumer goods, it maintained significant positions in healthcare-related equities such as Tenet Healthcare. The firm reached peak assets under management of approximately $2.3 billion in 2012 before shuttering its operations and returning capital to investors in late 2014.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Merchants’ Gate Capital.